相关实验视频

Updated: Jun 27, 2025

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

Published on: November 12, 2019

卵巢癌中的CAR-T细胞疗法:我们现在在哪里?

Clare Cutri-French¹, Dimitrios Nasioudis², Erin George³

¹Department of Obstetrics and Gynecology, University of Pennsylvania Health System, Philadelphia, PA 19104, USA.

Diagnostics (Basel, Switzerland)

|April 26, 2024

概括

化学抗原受体T细胞 (CAR-T) 疗法对卵巢癌具有前景,向特定的蛋白质. 挑战包括瘤微环境和毒性,但正在进行的试验正在探索其潜力.

科学领域:

免疫学免疫学免疫学
在瘤学瘤学.
生物技术是生物技术.

背景情况:

化学抗原受体T细胞 (CAR-T) 疗法彻底改变了血液恶性瘤的治疗方法.
现在正在探索其对固体瘤,特别是卵巢癌的潜力.
卵巢癌微环境对CAR-T细胞的疗效提出了重大挑战.

研究的目的:

审查在卵巢癌中CAR-T细胞治疗的现状.
讨论正在进行的临床试验和治疗目标.
确定卵巢癌中CAR-T治疗的挑战和未来方向.

主要方法:

对卵巢癌中CAR-T疗法的早期临床试验的审查.
分析CAR-T细胞标,包括美索林,叶酸受体α,HER2,MUC16和B7H3.3.
与CAR-T疗法相关的常见不良事件和毒性的摘要.

主要成果:

一些针对特定抗原的CAR-T细胞疗法正在早期临床试验中进行研究.
常见的毒性包括细胞因子释放综合征,HLH/MAS和神经毒性.
"在点,瘤外"效应和免疫抑制瘤微环境仍然是重要的障碍.

结论:

尽管存在挑战,但CAR-T疗法对卵巢癌的治疗有潜力.
进一步的研究和临床试验是必要的,以优化疗效和管理毒性.
克服免疫抑制瘤微环境对于成功实施CAR-T至关重要.

关键词:

在CAR-T疗法中,梅索他林是其中一种.卵巢癌是发生在卵巢的癌症.目标抗原的目标抗原.

更多相关视频

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...